Hemodynamic Support Devices

This hemodynamic support systems channel includes content on intra-aortic balloon pumps (IABP), percutaneous ventricular assist devices (pVAD) like the Impella or TandemHeart, extracorporeal membrane oxygenation (ECMO), and ventricular assist devices (VAD). This channel also includes use of these devices in support of patients in cardiogenic shock and advanced heart failure

Videos | Cardiogenic Shock

Srihari Naidu, M.D., FACC, FAHA, FSCAI, is the director of both the cardiac cath labs and Hypertrophic Cardiomyopathy ...

Home November 16, 2021
product comparison charts for cardiology and health IT systems

Diagnostic and Interventional Cardiology (DAIC) magazine maintains more than 50 comparison charts of product ...

Home November 07, 2021
News | Intra-Aortic Balloon Pumps (IABP)

 November 2, 2021 — Datascope/Getinge/Maquet is recalling its Cardiosave Hybrid/Rescue Intra-Aortic Balloon Pumps (IABP) ...

Home November 02, 2021
News | Ventricular Assist Devices (VAD)

October 20, 2021 – CorWave, a French medtech company developing a next-generation heart pump, won the 2021 HealthTech ...

Home October 20, 2021
News | Heart Failure

September 22, 2021 — A cardiothoracic surgical team with University of Louisville Health – Jewish Hospital has performed ...

Home September 22, 2021
News | ECMO Systems

September 13, 2021 — The growing use of mechanical circulatory support (MCS) may contribute to high levels of moral ...

Home September 13, 2021
Medtronic announced in June it was stopping the sale and distribution of the Medtronic Heartware HVAD left ventricular assist device (LVAD). Abbott announced the same day it has the capacity to meet increased demand for LVADs as Medtronic leaves the market.
Feature | Ventricular Assist Devices (VAD) | By Dave Fornell, Editor

Medtronic announced in June it was stopping the sale and distribution of the Medtronic Heartware HVAD left ventricular ...

Home July 08, 2021
News | Artificial Heart

June 18, 2021 – An experimental artificial heart includes an autoregulation control mechanism, or Auto-Mode, that can ...

Home June 23, 2021
News | Antiplatelet and Anticoagulation Therapies

June 21, 2021 — The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's dabigatran etexilate ...

Home June 21, 2021
News | Heart Failure

June 7, 2021 – Cardiologists at Henry Ford Hospital are first in the U.S. and second in the world to implant a ...

Home June 07, 2021
ECMO unit in use to support a severely ill patient at the University of Michigan. ECMO was shown to imporve survival and neuro outcomes in sudden cardiac arrest patients who do not respond to standard therapy.
Feature | Sudden Cardiac Arrest

May 19, 2021 — A subgroup of patients who experienced an out-of-hospital cardiac arrest (OHCA) that did not respond to ...

Home May 19, 2021
The Abiomed Impella percutaneous heart pump was shown in the NCSI study to greatly improve survival of acute myocardial infarction with cardiogenic shock (AMICS), raising survival from 50 percent to 71 percent. Ambulance image from Getty Images.
Feature | Cardiogenic Shock | By Dave Fornell, Editor

April 29, 2021 — The results of a large, national heart attack study show that patients with  cardiogenic shock survived ...

Home April 29, 2021
Videos | Ventricular Assist Devices (VAD)

Surgeons at Penn State Heart and Vascular Institute were the second group in the nation to implant a newly-designed ...

Home March 22, 2021
The Teleflex Manta large-bore vascular closure device can seal holes between 12 and 25 French.
Feature | Hemostasis Management | Dave Fornell, Editor

While many cardiac and vascular procedures have largely moved to minimally invasive techniques, the size of these ...

Home March 09, 2021
Subscribe Now